Cyclosporine in Pancreatitis

Cyclosporine in Pancreatitis Study

Aim of Study

Evaluate cyclosporine as a novel therapy for dogs with insulin-resistant diabetes mellitus and chronic pancreatitis.

There is some evidence in the human literature that chronic pancreatitis may have an underlying immune-mediated etiology and anecdotally, cyclosporine has resulted in improved diabetic control in a dog with chronic pancreatitis as a cause of insulin resistance.

Client Incentives

Qualifying cases will receive Atopica free of charge for the trial period of six weeks.

Enrollment

For more information please contact Dr. Sina Marsilio at smarsilio@cvm.tamu.edu.